Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cancer Research|March 22, 2018
Germline Lysine-Specific Demethylase 1 (<i>LSD1/KDM1A</i>) Mutations Confer Susceptibility to Multiple MyelomaXiaomu Wei, M Nieves Calvo-Vidal, Siwei Chen, et al.
Journal of the National Cancer Institute|August 18, 2021
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal CancersAndrea Cercek, Walid K Chatila, Rona Yaeger, et al.
Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.
JAMA|September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingDiana Mandelker, Liying Zhang, Yelena Kemel, et al.
Breast Cancer Research : BCR|July 2, 2013
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration, Melissa C Southey, Daniel J Park, et al.
British Journal of Haematology|March 24, 2026
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation studyYolanda Benavente, Sara Hermosa, Nikos Papadimitriou, et al.
European Urology|May 20, 2023
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational InsightsStella Koutros, Lambertus A Kiemeney, Parichoy Pal Choudhury, et al.
Nature Communications|February 7, 2017
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemiaPhilip J Law, Sonja I Berndt, Helen E Speedy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2021
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variantInge M M Lakeman, Alexandra J van den Broek, Juliën A M Vos, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
Pageof 6